CellVoyant is an AI-first biotechnology company dedicated to accelerating the development of life-changing therapies aimed at curing chronic diseases. By integrating advanced artificial intelligence with live cell imaging, CellVoyant predicts and optimizes stem cell differentiation processes. This innovative approach enables precise cell analytics and process development, facilitating the scalable and controllable manufacturing of any cell or tissue type within the human body. Operating at the intersection of cell biology, computer vision, engineering, and machine learning, CellVoyant is committed to transforming next-generation scientific research into real-world applications.